TUDOR INVESTMENT CORP ET AL

Position in OGN — Organon & Co.

CIK 923093 STAMFORD, CT

Position in OGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$151,377

-$73,427 QoQ

Shares Held

11,180

-70.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#258

of 626 holders

Holding Since

Dec 2023

4 quarters on record

Voting authority Sole 50% Shared 50% None 0%

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $79,702,583 across 6 Drug Manufacturers - General names. OGN ranks #6 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	30,885	$37,044,398
2	PFE	Pfizer Inc	697,000	$16,783,760
3	GILD	Gilead Sciences, Inc.	74,896	$9,462,360
4	NVO	Novo Nordisk A S	182,382	$8,743,393
5	AZN	Astrazeneca PLC	39,644	$7,517,295
6	OGN	Organon & Co. This page	11,180	$151,377

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$151,377	11,180	-70.2%	Shares	Defined	2026-08-14
2026-03-31	$224,804	37,530	+57.8%	Shares	Defined	2026-05-15
2024-03-31	$447,139	23,784	+28.5%	Shares	Defined	2024-05-15
2023-12-31	$266,899	18,509	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.